F.D.A. Panel Debates ‘Black Box’ Warning for Antidepressants in Pregnancynews2025-07-21T22:23:23+00:00July 21st, 2025|The New York Times|
Trump Administration’s N.I.H. and F.D.A. Cuts Could Curtail New Drug Development, Budget Office Saysnews2025-07-18T16:08:45+00:00July 18th, 2025|The New York Times|
F.D.A. Posts Collection of Letters Outlining Concerns About New Drugsnews2025-07-10T21:42:29+00:00July 10th, 2025|The New York Times|
What to Know About the Collapse of the F.D.A.news2025-07-08T09:01:49+00:00July 8th, 2025|The New York Times|
F.D.A. to Use A.I. in Drug Approvals to ‘Radically Increase Efficiency’news2025-06-10T18:30:10+00:00June 10th, 2025|The New York Times|
Kennedy Says ‘Charlatans’ Are No Reason to Block Unproven Stem Cell Treatmentsnews2025-06-05T16:07:54+00:00June 5th, 2025|The New York Times|
Who is Calley Means, Kennedy’s Health Adviser?news2025-05-22T09:03:22+00:00May 22nd, 2025|The New York Times|
Trump Seeks to Lower Drug Prices Through Medicare and Some Importsnews2025-04-16T15:13:36+00:00April 16th, 2025|The New York Times|
RFK Jr. Accuses FDA of Drug Industry Influence That Barred Alternative Remediesnews2025-04-12T01:06:20+00:00April 12th, 2025|The New York Times|
La derecha en EE. UU. sigue defendiendo a la ivermectinanews2025-04-01T14:33:37+00:00April 1st, 2025|The New York Times|
